drugset / Trial / NCT02728245

Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma

NCT02728245 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Randomized phase 2 trial comparing preoperative dienogest therapy followed by surgery vs. upfront surgery to save ovarian reserve in young women with ovarian endometrioma

Timeline

Start
2017-10
Primary completion
2018-03
Completion
2018-03

Outcome

Outcome not reported

Stopped: “Placebo cannot be prepared”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule 2 mg Oral

Indications